FABENTECH
Founded in 2009, Fabentech specialises in the development and production of broad-spectrum therapeutics for fighting high-priority biological agents which could threaten public health.
Lobbying Activity
Meeting with Laurent Muschel (Director Health Emergency Preparedness and Response Authority) and
10 Nov 2025 · Medical countermeasures developed by Fabentech
Response to Communication on the EU Stockpiling Strategy
29 Apr 2025
Meeting with Christian Ehler (Member of the European Parliament) and
4 Sept 2024 · Implementation of Horizon Europe
Meeting with Christian Ehler (Member of the European Parliament)
30 Aug 2024 · Preparation meeting